Professor Eva Segelov |
Professor Segelov's appointment is an acting role for three months whilst current Clinical Director Peter Briggs is on extended leave. Professor Segelov will provide leadership and clinical expertise to both SMICS and Monash Partners Comprehensive Cancer Consortium (MPCCC).
An agency of the Victorian Government, SMICS ensures appropriate links exist between the health services in Southern Melbourne, to optimise the experience and treatment pathways for people affected by cancer.
Professor Segelov said that SMICS is pivotal in ensuring strong coordination and planning across the region, to improve the quality and continuity of patient care.